When you go to market with a therapeutic product, marketed at GP, you'll use pharma sales reps to encourage GPs / Specialists to prescribe the drug. If your product at market hasn't gone through all the hoops at testing, your competing sales rep will pull it apart "ah, but they haven't tested their for stability yet, you should prescribe our product". Getting a drug to market is a long expensive process. The best thing about cannabis products is it grows on tress, is a simple solvent extraction and heat based activation so production is relatively cheap.
- Forums
- ASX - By Stock
- CAN
- Ann: Commercial-scale GMP medicinal cannabis resin extraction
Ann: Commercial-scale GMP medicinal cannabis resin extraction, page-46
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
-0.003(6.25%) |
Mkt cap ! $21.57M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.5¢ | $21.48K | 469.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 342919 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 24419 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250000 | 0.045 |
1 | 100000 | 0.044 |
1 | 20000 | 0.043 |
2 | 34285 | 0.042 |
2 | 274390 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 24419 | 1 |
0.050 | 110000 | 2 |
0.053 | 751251 | 2 |
0.054 | 608758 | 3 |
0.055 | 162929 | 6 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online